Førsteamanuensis

Line Wergeland

FLT3-ITD mutations in acute myeloid leukaemia – molecular characteristics, distribution and numerical variation

Engen, Caroline, Hellesøy, Monica, Grob, Tim, Al Hinai, Adil, Brendehaug, Atle, Wergeland, Line, Bedringaas, Siv Lise, Hovland, Randi, Valk, Peter J. M., Gjertsen, Bjørn T. (2021)

Molecular Oncology 2021 Volum 15 ;(9)s. 2300-2317
Targeted Therapy of FLT3 in Treatment of AML-Current Status and Future Directions

Engen, Caroline Benedicte Nitter, Wergeland, Line, Skavland, Jørn, Gjertsen, Bjørn Tore (2014)

Journal of Clinical Medicine 2014
Målrettet behandling av akutt myelogen leukemi - hemmere mot FLT3 og andre kinaser viser vei

Engen, Caroline Benedicte Nitter, Wergeland, Line, Gjertsen, Bjørn Tore (2013)

Best Practice 2013
Expression of TP53 isoforms p53 beta or p53 gamma enhances chemosensitivity in TP53(null) cell lines

Silden, Elisabeth, Hjelle, Sigrun Margrethe, Wergeland, Line, Sulen, Andre, Andresen, Vibeke, Bourdon, Jean-Christophe, Micklem, David Robert, McCormack, Emmet, Gjertsen, Bjørn Tore (2013)

PLOS ONE 2013 Volum 8 ;(2)
Ectopic expression of Flt3 kinase inhibits proliferation and promotes cell death in different human cancer cell lines

Oveland, Eystein, Wergeland, Line, Hovland, Randi, Lorens, James, Gjertsen, Bjørn Tore, Fladmark, Kari Espolin (2012)

Cell Biology and Toxicology 2012 Volum 28 ;(4)s. 201-212